ArticleCancer management and research2022

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.

Katja Sockel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.